Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Review article: Biomedical intelligence

Vol. 154 No. 7 (2024)

Peripheral lymphadenopathy of unknown origin in adults: a diagnostic approach emphasizing the malignancy hypothesis

DOI
https://doi.org/10.57187/s.3549
Cite this as:
Swiss Med Wkly. 2024;154:3549
Published
31.07.2024

Summary

The term lymphadenopathy refers to an abnormality in size, consistency or morphological aspect of one or several lymph nodes. Although lymphadenopathies are commonly observed in everyday clinical practice, the difficulty of differentiating benign and malignant disease may delay therapeutic approaches. The present review aims to update diagnostic algorithms in different clinical situations based on the currently available literature.

A literature review was performed to assess current knowledge of and to update the diagnostic approach. A short clinical vignette was used as an example of a typical clinical presentation. This case of metastatic lymphadenopathy with incomplete patient history demonstrates how misleading such lymphadenopathy may be, leading to a delayed diagnosis and even a fatal outcome.

Any lymphadenopathy persisting for more than 2 weeks should be considered suspicious and deserves further investigation. Precise clinical examination, meticulous history-taking and a search for associated symptomatology are still cornerstones for diagnosing the origin of the condition. The next diagnostic step depends on the anatomical region and the specific patient’s situation. Imaging starts with ultrasound, while computed tomography (CT) and magnetic resonance imaging (MRI) allow assessment of the surrounding structures. If the diagnosis remains uncertain, tissue sampling and histological analyses should be performed.

Except for head and neck loco-regional lymphadenopathy, there are no methodical guidelines for persistent lymphadenopathy. The present review clarifies several confusing and complex situations. The accuracy of fine needle aspiration cytology could be increased by using core needle biopsy with immunocytologic and flow cytometric methods. Notably, except in the head and neck area, open biopsy remains the best option when lymphoma is suspected or when inconclusive results of previous fine needle aspiration cytology or core needle biopsy are obtained. The incidence of malignant lymphadenopathy varies with its location and the various diagnostic strategies. In metastatic lymphadenopathy of unknown primary origin, European Society for Medical Oncology (ESMO) guidelines and modern methods like next-generation sequencing (NGS) may help to manage such complex cases.

References

  1. Gaddey HL, Riegel AM. Unexplained Lymphadenopathy: evaluation and differential diagnosis . Am Fam Physician. 2016 Dec;94(11):896–903. https://www.aafp.org/afp/2016/1201/p896.html
  2. Newton MV, Ramesh RS, Manjunath S, ShivaKumar K, Nanjappa HG, Damuluri R, et al. Histological Surprises in Benign Cytologies after Lymph Node Biopsy-Surgeon’s Knife Improving Patient Care. Indian J Surg Oncol. 2017 Jun;8(2):113–8. 10.1007/s13193-016-0577-2 DOI: https://doi.org/10.1007/s13193-016-0577-2
  3. Farooq A, Ameen I. Comparison of FNAC vs Excision Biopsy for suspected Tuberculous Cervical Lymphadenopathy . Ann King Edw Med Univ. 2016 Jul;9(3): https://www.annalskemu.org/journal/index.php/annals/article/view/1343 10.21649/akemu.v9i3.1343 DOI: https://doi.org/10.21649/akemu.v9i3.1343
  4. Health Quality Ontario. The Accuracy of Fine-Needle Aspiration Cytology in the Diagnosis of Lymphoma. Ontario; 2014 Oct. http://www.hqontario.ca/evidence/publications-and-ohtac-recommendations/rapid-reviews
  5. Novoa E, Gürtler N, Arnoux A, Kraft M. Role of ultrasound-guided core-needle biopsy in the assessment of head and neck lesions: a meta-analysis and systematic review of the literature. Head Neck. 2012 Oct;34(10):1497–503. 10.1002/hed.21821 DOI: https://doi.org/10.1002/hed.21821
  6. Morris-Stiff G, Cheang P, Key S, Verghese A, Havard TJ. Does the surgeon still have a role to play in the diagnosis and management of lymphomas? World J Surg Oncol. 2008 Feb;6(1):13. 10.1186/1477-7819-6-13 DOI: https://doi.org/10.1186/1477-7819-6-13
  7. Metzgeroth G, Schneider S, Walz C, Reiter S, Hofmann WK, Marx A, et al. Fine needle aspiration and core needle biopsy in the diagnosis of lymphadenopathy of unknown aetiology. Ann Hematol. 2012 Sep;91(9):1477–84. 10.1007/s00277-012-1476-4 DOI: https://doi.org/10.1007/s00277-012-1476-4
  8. Pyo JS, Jung J, Lee SG, Kim NY, Kang DW. Diagnostic Accuracy of Fine-Needle Aspiration Cytology and Core-Needle Biopsy in the Assessment of the Axillary Lymph Nodes in Breast Cancer-A Meta-Analysis. Diagnostics (Basel). 2020 Sep;10(9):717. 10.3390/diagnostics10090717 DOI: https://doi.org/10.3390/diagnostics10090717
  9. Pynnonen MA, Gillespie MB, Roman B, Rosenfeld RM, Tunkel DE, Bontempo L, et al. Clinical Practice Guideline: Evaluation of the Neck Mass in Adults. Otolaryngol - Head Neck Surg (United States). 2017;157(2_suppl). DOI: https://doi.org/10.1177/0194599817722550
  10. Khare P. Cytopathological Pattern of Tubercular Lymphadenopathy on FNAC: Analysis of 550 Consecutive Cases. J Clin DIAGNOSTIC Res; 2014. DOI: https://doi.org/10.7860/JCDR/2014/9956.4910
  11. Kühnl A, Cunningham D, Hutka M, Peckitt C, Rozati H, Morano F, et al. Rapid access clinic for unexplained lymphadenopathy and suspected malignancy: prospective analysis of 1000 patients. BMC Hematol. 2018 Aug;18(1):19. 10.1186/s12878-018-0109-0 DOI: https://doi.org/10.1186/s12878-018-0109-0
  12. Zenga J, Graboyes EM, Haughey BH, Paniello RC, Mehrad M, Lewis JS, et al. Definitive Surgical Therapy after Open Neck Biopsy for HPV-Related Oropharyngeal Cancer. United States: Otolaryngology - Head and Neck Surgery; 2016. 10.1177/0194599815627642 DOI: https://doi.org/10.1177/0194599815627642
  13. Moor JW, Murray P, Inwood J, Gouldesbrough D, Bem C. Diagnostic biopsy of lymph nodes of the neck, axilla and groin: rhyme, reason or chance? Ann R Coll Surg Engl. 2008 Apr;90(3):221–5. 10.1308/003588408X242105 DOI: https://doi.org/10.1308/003588408X242105
  14. Chau I, Kelleher MT, Cunningham D, Norman AR, Wotherspoon A, Trott P, et al. Rapid access multidisciplinary lymph node diagnostic clinic: analysis of 550 patients. Br J Cancer. 2003 Feb;88(3):354–61. 10.1038/sj.bjc.6600738 DOI: https://doi.org/10.1038/sj.bjc.6600738
  15. World Health Organization GTR. Incidence of tuberculosis (per 100,000 people) - Switzerland. https://data.worldbank.org/indicator/SH.TBS.INCD?locations=CH. 2021.
  16. Nathalie Gasser. Cantonal tuberculosis activities 2021. Bern; 2021 Oct.
  17. Akkina SR, Kim RY, Stucken CL, Pynnonen MA, Bradford CR. The current practice of open neck mass biopsy in the diagnosis of head and neck cancer: A retrospective cohort study. Laryngoscope Investig Otolaryngol. 2019 Jan;4(1):57–61. 10.1002/lio2.240 DOI: https://doi.org/10.1002/lio2.240
  18. Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A. Peripheral lymphadenopathy: approach and diagnostic tools. Iran J Med Sci. 2014 Mar;39(2 Suppl):158–70.
  19. Landes M, Maor Y, Mercer D, Habot-Wilner Z, Bilavsky E, Chazan B, et al. Cat Scratch Disease Presenting as Fever of Unknown Origin Is a Unique Clinical Syndrome. Clin Infect Dis. 2020 Dec;71(11):2818–24. 10.1093/cid/ciz1137 DOI: https://doi.org/10.1093/cid/ciz1137
  20. Freeman AM, Matto P. [] StatPearls []: ; 2024., Available from https://www.ncbi.nlm.nih.gov/books/NBK513250/
  21. Miranda RN, Khoury JD, Medeiros LJ. Lymphadenopathy Secondary to Drug-Induced Hypersensitivity Syndrome. Atlas of Lymph Node Pathology. New York (NY): Springer New York; 2013. pp. 157–60. 10.1007/978-1-4614-7959-8_37 DOI: https://doi.org/10.1007/978-1-4614-7959-8_37
  22. Mauch PM, Kalish LA, Kadin M, Coleman CN, Osteen R, Hellman S. Patterns of presentation of Hodgkin disease. Implications for etiology and pathogenesis. Cancer. 1993 Mar;71(6):2062–71. 10.1002/1097-0142(19930315)71:6<2062::AID-CNCR2820710622>3.0.CO;2-0 DOI: https://doi.org/10.1002/1097-0142(19930315)71:6<2062::AID-CNCR2820710622>3.0.CO;2-0
  23. Laurent C, Do C, Gourraud PA, De Paiva GR, Valmary S, Brousset P. Prevalence of common non-hodgkin lymphomas and subtypes of hodgkin lymphoma by nodal site of involvement. Volume 94. United States: Medicine; 2015. DOI: https://doi.org/10.1097/MD.0000000000000987
  24. Al Kadah B, Popov HH, Schick B, Knöbber D. Cervical lymphadenopathy: study of 251 patients. Eur Arch Oto-Rhino-Laryngology. 2015;272(3). 10.1007/s00405-014-3315-9 DOI: https://doi.org/10.1007/s00405-014-3315-9
  25. Aulino JM, Kirsch CF, Burns J, Busse PM, Chakraborty S, Choudhri AF, et al.; Expert Panel on Neurologic Imaging. ACR Appropriateness Criteria® Neck Mass-Adenopathy. J Am Coll Radiol. 2019 May;16(5 5S):S150–60. 10.1016/j.jacr.2019.02.025 DOI: https://doi.org/10.1016/j.jacr.2019.02.025
  26. Ouyang L, Shi ZY, Lin ZG. 18F-FDG PET/CT makes a significant contribution to diagnosis of malignancy in patients with cervical lymphadenopathy: a study using optimal scale regression tests. Chin Med J (Engl). 2013 Feb;126(4):659–67. 10.3760/cma.j.issn.0366-6999.20121483 DOI: https://doi.org/10.3760/cma.j.issn.0366-6999.20121483
  27. Redondo-Cerezo E, Martínez-Cara JG, Esquivias J, de la Torre-Rubio P, González-Artacho C, García-Marín MC, et al. Endoscopic ultrasonography-fine needle aspiration versus PET-CT in undiagnosed mediastinal and upper abdominal lymphadenopathy: a comparative clinical study. Eur J Gastroenterol Hepatol. 2015 Apr;27(4):455–9. 10.1097/MEG.0000000000000302 DOI: https://doi.org/10.1097/MEG.0000000000000302
  28. Chen J, Xu D, Sun WJ, Wang WX, Xie NN, Ruan QR, et al. Differential diagnosis of lymphoma with 18F-FDG PET/CT in patients with fever of unknown origin accompanied by lymphadenopathy. J Cancer Res Clin Oncol. 2023 Aug;149(10):7187–96. 10.1007/s00432-023-04665-7 DOI: https://doi.org/10.1007/s00432-023-04665-7
  29. Krämer A, Bochtler T, Pauli C, Baciarello G, Delorme S, Hemminki K, et al.; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023 Mar;34(3):228–46. 10.1016/j.annonc.2022.11.013 DOI: https://doi.org/10.1016/j.annonc.2022.11.013
  30. David S. Ettinger M, Marvaretta M. Stevenson MC. Occult Primary (Cancer of Unknown Primary [CUP]). 2022 Dec.
  31. Caputo A, Caleo A, Cozzolino I, Zeppa P, Ciancia G, Ciliberti V. COVID-19 post-vaccination lymphadenopathy: A review of the use of fine needle aspiration cytology. Cytopathology. 2023 Sep;34(5):423–32. 10.1111/cyt.13221 DOI: https://doi.org/10.1111/cyt.13221
  32. Wilczynski A, Görg C, Timmesfeld N, Ramaswamy A, Neubauer A, Burchert A, et al. Value and Diagnostic Accuracy of Ultrasound-Guided Full Core Needle Biopsy in the Diagnosis of Lymphadenopathy: A Retrospective Evaluation of 793 Cases. J Ultrasound Med. 2020 Mar;39(3):559–67. 10.1002/jum.15134 DOI: https://doi.org/10.1002/jum.15134
  33. Johl A, Lengfelder E, Hiddemann W, Klapper W; German Low-grade Lymphoma Study Group (GLSG). Core needle biopsies and surgical excision biopsies in the diagnosis of lymphoma-experience at the Lymph Node Registry Kiel. Ann Hematol. 2016 Aug;95(8):1281–6. 10.1007/s00277-016-2704-0 DOI: https://doi.org/10.1007/s00277-016-2704-0
  34. Eichenauer DA, Aleman BM, André M, Federico M, Hutchings M, Illidge T, et al.; ESMO Guidelines Committee. Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018 Oct;29 Suppl 4:iv19–29. 10.1093/annonc/mdy080 DOI: https://doi.org/10.1093/annonc/mdy080
  35. Seviar D, Yousuff M, Chia Z, Ramesar K, Newman J, Howlett DC. Image-guided core needle biopsy as the first-line diagnostic approach in lymphoproliferative disorders-A review of the current literature. Eur J Haematol. 2021 Feb;106(2):139–47. 10.1111/ejh.13532 DOI: https://doi.org/10.1111/ejh.13532
  36. Warshavsky A, Rosen R, Perry C, Muhanna N, Ungar OJ, Carmel-Neiderman NN, et al. Core needle biopsy for diagnosing lymphoma in cervical lymphadenopathy: meta-analysis. Head Neck. 2020 Oct;42(10):3051–60. 10.1002/hed.26381 DOI: https://doi.org/10.1002/hed.26381
  37. Pizzi M, Sbaraglia M, Dal Santo L, De Bartolo D, Santoro L, Scarmozzino F, et al. Higher accuracy of surgical over core needle biopsy for the diagnosis of lymphoproliferative disorders. Int J Lab Hematol. 2023 Aug;45(4):516–21. 10.1111/ijlh.14055 DOI: https://doi.org/10.1111/ijlh.14055
  38. Shah A, Ross C, Sur M. An approach to small lymph node biopsies: pearls and pitfalls of reporting in the real world. J Am Soc Cytopathol. 2021;10(3):328–37. 10.1016/j.jasc.2020.12.006 DOI: https://doi.org/10.1016/j.jasc.2020.12.006
  39. Volaric AK, Lin O, Balassanian R, Cook S, Falchi L, Fitzpatrick MJ, et al.; Cyto-Heme Institutional Collaborative (CHIC) Consortium. Diagnostic Discrepancies in Small-volume Biopsy for the Initial Diagnosis, Recurrence, and Transformation of Follicular Lymphoma: A Multi-Institutional Collaborative Study. Am J Surg Pathol. 2023 Feb;47(2):212–7. 10.1097/PAS.0000000000001985 DOI: https://doi.org/10.1097/PAS.0000000000001985
  40. Caputo A, Fraggetta F, Cretella P, Cozzolino I, Eccher A, Girolami I, et al. Digital Examination of LYmph node CYtopathology Using the Sydney system (DELYCYUS): an international, multi-institutional study. Cancer Cytopathol. 2023 Nov;131(11):679–92. 10.1002/cncy.22741 DOI: https://doi.org/10.1002/cncy.22741
  41. Al-Abbadi MA, Barroca H, Bode-Lesniewska B, Calaminici M, Caraway NP, Chhieng DF, et al. A Proposal for the Performance, Classification, and Reporting of Lymph Node Fine-Needle Aspiration Cytopathology: the Sydney System. Acta Cytol. 2020;64(4):306–22. 10.1159/000506497 DOI: https://doi.org/10.1159/000506497
  42. Peluso AL, Ieni A, Mignogna C, Zeppa P. Lymph Node Fine-Needle Cytology: Beyond Flow Cytometry. Acta Cytol. 2016;60(4):372–84. 10.1159/000447734 DOI: https://doi.org/10.1159/000447734
  43. Prudent E, La Scola B, Drancourt M, Angelakis E, Raoult D. Molecular strategy for the diagnosis of infectious lymphadenitis. Eur J Clin Microbiol Infect Dis. 2018 Jun;37(6):1179–86. 10.1007/s10096-018-3238-2 DOI: https://doi.org/10.1007/s10096-018-3238-2
  44. Afzal W, Arab T, Ullah T, Teller K, Doshi KJ. Generalized Lymphadenopathy as Presenting Feature of Systemic Lupus Erythematosus: Case Report and Review of the Literature. J Clin Med Res. 2016 Nov;8(11):819–23. 10.14740/jocmr2717w DOI: https://doi.org/10.14740/jocmr2717w
  45. Habermann TM, Steensma DP. Lymphadenopathy. Mayo Clin Proc. 2000 Jul;75(7):723–32. 10.1016/S0025-6196(11)64620-X DOI: https://doi.org/10.4065/75.7.723
  46. Victor C, Kota AA, Colney L, Roopavathana B, Chase S, Nayak S. An audit to study the diagnostic yield of lymph node biopsies under local anaesthesia. Int Surg J. 2020;7(6):1804. 10.18203/2349-2902.isj20202385 DOI: https://doi.org/10.18203/2349-2902.isj20202385
  47. Storck K, Brandstetter M, Keller U, Knopf A. Clinical presentation and characteristics of lymphoma in the head and neck region. Head Face Med. 2019 Jan;15(1):1. 10.1186/s13005-018-0186-0 DOI: https://doi.org/10.1186/s13005-018-0186-0
  48. Akinci S, Silay K, Hacibekiroglu T, Ulas A, Basturk A, Bakanay SM, et al. The predictive value of epidemiological characteristics, clinical and laboratory findings in adult lymphadenopathy etiology. Eur Rev Med Pharmacol Sci. 2015 Aug;19(16):2973–7.
  49. Franzen A, Günzel T, Buchali A, Coordes A. Etiologic and differential diagnostic significance of tumor location in the supraclavicular fossa. Laryngoscope. 2018 Mar;128(3):646–50. 10.1002/lary.26775 DOI: https://doi.org/10.1002/lary.26775
  50. Ahamed SH, Agarwal AK, Raju PP. Metastatic prostate carcinoma presenting as supraclavicular lymphadenopathy - is it unusual? Ann R Coll Surg Engl. 2006 Oct;88(6):W4-5. 10.1308/147870806X129278 DOI: https://doi.org/10.1308/147870806X129278
  51. Carrier C. Adénopathie biopsie ou observation? Méd Qué. 2012 Oct;47(10):39–44.
  52. Husain M, Khan S, Bhat A, Hajini F. Accessory breast tissue mimicking pedunculated lipoma. Case Reports. 2014 Jul 8;2014(jul08 1):bcr2014204990–bcr2014204990. 10.1136/bcr-2014-204990 DOI: https://doi.org/10.1136/bcr-2014-204990
  53. Shipchandler TZ, Lorenz RR, McMahon J, Tubbs R. Supraclavicular lymphadenopathy due to silicone breast implants. Arch Otolaryngol Head Neck Surg. 2007 Aug;133(8):830–2. 10.1001/archotol.133.8.830 DOI: https://doi.org/10.1001/archotol.133.8.830
  54. Olivier JB, Verhaeghe JL, Butarelli M, Marchal F, Houvenaeghel G. Anatomie fonctionnelle du drainage lymphatique du sein : apport de la technique du lymphonoeud sentinelle. Ann Chir. 2006 Dec;131(10):608–15. 10.1016/j.anchir.2006.06.011 DOI: https://doi.org/10.1016/j.anchir.2006.06.011
  55. Lathrop KI, Kaklamani V. Unknown Primary Presenting With Axillary Lymphadenopathy. The Breast. Elsevier; 2018. pp. 1000–1003.e1. 10.1016/B978-0-323-35955-9.00079-9 DOI: https://doi.org/10.1016/B978-0-323-35955-9.00079-9
  56. D’Orsi CJ, Sickles EA, Mendelson EB, Morris EA. ACR BI-RADS® -Atlas, breast imaging reporting and data system. 5th edn. Reston, VA, USA; 2013.
  57. Newman LA, Kuerer HM, Fornage B, Mirza N, Hunt KK, Ross MI, et al. Adverse prognostic significance of infraclavicular lymph nodes detected by ultrasonography in patients with locally advanced breast cancer. Am J Surg. 2001 Apr;181(4):313–8. 10.1016/S0002-9610(01)00588-8 DOI: https://doi.org/10.1016/S0002-9610(01)00588-8
  58. Hiller N, Goldberg SN, Cohen-Cymberknoh M, Vainstein V, Simanovsky N. Lymphadenopathy Associated With the COVID-19 Vaccine. Cureus. 2021 Feb;13(2):e13524. DOI: https://doi.org/10.7759/cureus.13524
  59. Taweesedt PT, Surani S. Mediastinal lymphadenopathy in COVID-19: A review of literature. World J Clin Cases. 2021 Apr;9(12):2703–10. 10.12998/wjcc.v9.i12.2703 DOI: https://doi.org/10.12998/wjcc.v9.i12.2703
  60. Schroeder DG, Jang S, Johnson DR, Takahashi H, Navin PJ, Broski SM, et al. Frequency and Characteristics of Nodal and Deltoid FDG and 11C-Choline Uptake on PET Performed After COVID-19 Vaccination. AJR Am J Roentgenol. 2021 Nov;217(5):1206–16. 10.2214/AJR.21.25928 DOI: https://doi.org/10.2214/AJR.21.25928
  61. Schiaffino S, Pinker K, Magni V, Cozzi A, Athanasiou A, Baltzer PA, et al. Axillary lymphadenopathy at the time of COVID-19 vaccination: ten recommendations from the European Society of Breast Imaging (EUSOBI). Insights Imaging. 2021 Aug;12(1):119. 10.1186/s13244-021-01062-x DOI: https://doi.org/10.1186/s13244-021-01062-x
  62. Hagen C, Nowack M, Messerli M, Saro F, Mangold F, Bode PK. Fine needle aspiration in COVID-19 vaccine-associated lymphadenopathy. Swiss Med Wkly. 2021 Jul;151(2930):w20557. 10.4414/smw.2021.20557 DOI: https://doi.org/10.4414/smw.2021.20557
  63. Vaz N, Franquet E, Heidari P, Chow DZ, Jacene HA, Ng TS. COVID-19: findings in nuclear medicine from head to toe. Clin Imaging. 2023 Jul;99:10–8. 10.1016/j.clinimag.2023.04.003 DOI: https://doi.org/10.1016/j.clinimag.2023.04.003
  64. Bontumasi N, Jacobson JA, Caoili E, Brandon C, Kim SM, Jamadar D. Inguinal lymph nodes: size, number, and other characteristics in asymptomatic patients by CT. Surg Radiol Anat. 2014 Dec;36(10):1051–5. 10.1007/s00276-014-1255-0 DOI: https://doi.org/10.1007/s00276-014-1255-0
  65. Hamilton W, Pascoe J, John J, Coats T, Davies S. Diagnosing groin lumps. Vol. 372. BMJ. 2021;n578. 10.1136/bmj.n578 DOI: https://doi.org/10.1136/bmj.n578
  66. Qin L, Zhao C, Wang H, Yang J, Chen L, Su X, et al. Detection of inguinal lymph nodes is promising for the diagnosis of periprosthetic joint infection. Front Cell Infect Microbiol. 2023 Apr;13:1129072. 10.3389/fcimb.2023.1129072 DOI: https://doi.org/10.3389/fcimb.2023.1129072
  67. Chalif J, Yao M, Gruner M, Kuznicki M, Vargas R, Rose PG, et al. Incidence and prognostic significance of inguinal lymph node metastasis in women with newly diagnosed epithelial ovarian cancer. Gynecol Oncol. 2022 Apr;165(1):90–6. 10.1016/j.ygyno.2022.01.026 DOI: https://doi.org/10.1016/j.ygyno.2022.01.026
  68. Swan MC, Furniss D, Cassell OC. Surgical management of metastatic inguinal lymphadenopathy. BMJ. 2004 Nov;329(7477):1272–6. 10.1136/bmj.329.7477.1272 DOI: https://doi.org/10.1136/bmj.329.7477.1272
  69. Giri S, Shah SH, Batra K, Anu-Bajracharya, Jain V, Shukla H, et al. Presentation and Management of Inguinal Lymphadenopathy in Ovarian Cancer. Indian J Surg Oncol. 2016 Dec;7(4):436–40. 10.1007/s13193-016-0556-7 DOI: https://doi.org/10.1007/s13193-016-0556-7
  70. Sehgal IS, Dhooria S, Aggarwal AN, Agarwal R. Impact of Rapid On-Site Cytological Evaluation (ROSE) on the Diagnostic Yield of Transbronchial Needle Aspiration During Mediastinal Lymph Node Sampling: Systematic Review and Meta-Analysis. Chest. 2018 Apr;153(4):929–38. 10.1016/j.chest.2017.11.004 DOI: https://doi.org/10.1016/j.chest.2017.11.004
  71. Scano V, Fois AG, Manca A, Balata F, Zinellu A, Chessa C, et al. Role of EBUS-TBNA in Non-Neoplastic Mediastinal Lymphadenopathy: review of Literature. Diagnostics (Basel). 2022 Feb;12(2):512. 10.3390/diagnostics12020512 DOI: https://doi.org/10.3390/diagnostics12020512
  72. Pathak V, Adhikari N, Conklin C. Management of Isolated Thoracic Lymphadenopathy of Unclear Etiology: A Survey of Physicians and Literature Review. Cureus. 2023 Jul;15(7):e41867. 10.7759/cureus.41867 DOI: https://doi.org/10.7759/cureus.41867
  73. Yardimci VH, Yardimci AH. An Unusual First Manifestation of Hodgkin Lymphoma: Epitrochlear Lymph Node İnvolvement-A Case Report and Brief Review of Literature. J Investig Med High Impact Case Rep. 2017 Apr;5(2):2324709617706709. 10.1177/2324709617706709 DOI: https://doi.org/10.1177/2324709617706709
  74. Catalano O, Nunziata A, Saturnino PP, Siani A. Epitrochlear lymph nodes: Anatomy, clinical aspects, and sonography features. Pictorial essay(). J Ultrasound. 2010 Dec;13(4):168–74. 10.1016/j.jus.2010.10.010 DOI: https://doi.org/10.1016/j.jus.2010.10.010
  75. Matter M, Nicod Lalonde M, Allaoua M, Boubaker A, Liénard D, Gugerli O, et al. The role of interval nodes in sentinel lymph node mapping and dissection for melanoma patients. J Nucl Med. 2007 Oct;48(10):1607–13. 10.2967/jnumed.107.041707 DOI: https://doi.org/10.2967/jnumed.107.041707
  76. Musters GD, Kleipool RP, Bipat S, Maas M. Features of the popliteal lymph nodes seen on musculoskeletal MRI in a Western population. Skeletal Radiol. 2011 Aug;40(8):1041–5. 10.1007/s00256-010-1093-z DOI: https://doi.org/10.1007/s00256-010-1093-z
  77. Hatta N, Morita R, Yamada M, Takehara K, Ichiyanagi K, Yokoyama K. Implications of popliteal lymph node detected by sentinel lymph node biopsy. Dermatol Surg. 2005 Mar;31(3):327–30. 10.1097/00042728-200503000-00014 DOI: https://doi.org/10.1097/00042728-200503000-00014
  78. Steen ST, Kargozaran H, Moran CJ, Shin-Sim M, Morton DL, Faries MB. Management of popliteal sentinel nodes in melanoma. J Am Coll Surg. 2011 Jul;213(1):180–6. 10.1016/j.jamcollsurg.2011.01.062 DOI: https://doi.org/10.1016/j.jamcollsurg.2011.01.062
  79. Thompson JF, Hunt JA, Culjak G, Uren RF, Howman-Giles R, Harman CR. Popliteal lymph node metastasis from primary cutaneous melanoma. Eur J Surg Oncol. 2000 Mar;26(2):172–6. 10.1053/ejso.1999.0765 DOI: https://doi.org/10.1053/ejso.1999.0765
  80. Dy BM, Shaha AR, Tuttle RM. The Delphian node revisited: an uncommon site of recurrence. J Endocr Soc. 2017 Nov;1(12):1527–30. 10.1210/js.2017-00333 DOI: https://doi.org/10.1210/js.2017-00333
  81. Nikolova PN, Hadzhiyska VH, Mladenov KB, Ilcheva MG, Veneva S, Grudeva VV, et al. The impact of 18F-FDG PET/CT in the clinical management of patients with lymph node metastasis of unknown primary origin. Neoplasma. 2021 Jan;68(1):180–9. 10.4149/neo_2020_200315N263 DOI: https://doi.org/10.4149/neo_2020_200315N263
  82. Reinert CP, Sekler J, la Fougère C, Pfannenberg C, Gatidis S. Impact of PET/CT on clinical management in patients with cancer of unknown primary-a PET/CT registry study. Eur Radiol. 2020 Mar;30(3):1325–33. 10.1007/s00330-019-06518-9 DOI: https://doi.org/10.1007/s00330-019-06518-9
  83. Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie e. V. Positronenemissionstomographie (PET) in der Onkologie. https://www.dgho.de/publikationen/stellungnahmen/g-ba/pet-pet-ct/positronenemissionstomographie-in-der-onkologie-2021.pdf. 2021.
  84. Zhou M, Wu Y, Wu Y, Li H, Ye B, Yue K, et al. Clinical characteristics and outcomes of cervical lymph node metastasis from unknown primary sites: a single institution’s 14-year experience. Eur J Med Res. 2023 Jan;28(1):5. 10.1186/s40001-022-00957-9 DOI: https://doi.org/10.1186/s40001-022-00957-9
  85. Fizazi K, Greco FA, Pavlidis N, Daugaard G, Oien K, Pentheroudakis G; ESMO Guidelines Committee. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up . Ann Oncol. 2015 Sep;26 Suppl 5:v133–8. https://linkinghub.elsevier.com/retrieve/pii/S0923753419471858 10.1093/annonc/mdv305 DOI: https://doi.org/10.1093/annonc/mdv305
  86. Wach MM, van Beek E, Ayabe R, Ruff S, Brown Z, Goldman DA, et al. Metastatic squamous cell carcinoma of known and unknown primary origin treated with axillary or inguinal lymphadenectomy. Am J Surg. 2018 Nov;216(5):963–8. 10.1016/j.amjsurg.2018.06.006 DOI: https://doi.org/10.1016/j.amjsurg.2018.06.006
  87. Richner S, Laifer G. Peripheral lymphadenopathy in immunocompetent adults. Swiss Med Wkly. 2010 Feb;140(7-8):98–104. 10.4414/smw.2010.12892 DOI: https://doi.org/10.4414/smw.2010.12892

Most read articles by the same author(s)